Higher circulating levels of OxLDL % of LDL are associated with subclinical atherosclerosis in female patients with systemic lupus erythematosus

Rheumatology International

Volumn 34, Issue 5, 2014, Pages 617-623

  Ahmad, Hamada Mohammad ^a   Sarhan, Esmat M ^b   Komber, Usama ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b Zagazig University   (Egypt)

Author keywords

Oxidized LDL; Subclinical atherosclerosis; Systemic lupus erythematosus

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN;

ADULT; ADVENTITIA; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; B SCAN; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY BIFURCATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; HUMAN; LIPID OXIDATION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ASYMPTOMATIC DISEASE; BLOOD; CAROTID ARTERY DISEASE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; ECHOGRAPHY; EGYPT; EPIDEMIOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREVALENCE; RISK; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; UPREGULATION; YOUNG ADULT;

ADULT; ASYMPTOMATIC DISEASES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EGYPT; FEMALE; HUMANS; LIPOPROTEINS, LDL; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; ODDS RATIO; PREVALENCE; RISK FACTORS; SEX FACTORS; UP-REGULATION; YOUNG ADULT;

EID: 84901274490     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2875-0     Document Type: Article

References (45)

1. Symmons DP, Gabriel SE (2011) Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 7(7):399-408
2. Manzi S, Wasko NCM (2000) Inflammation mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 59:321-325 (Pubitemid 30316772)
3. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, D'Agostino RB, Kuller LH (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145(5):408-415 (Pubitemid 27084212)
4. Thompson T, Sutton-Tyrrell K, Wildman RP et al (2008) Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus. Arthritis Rheum 58:835-842 (Pubitemid 351364882)
5. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Côte R, Grover SA, Fortin PR, Clarke AE, Senécal JL (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44(10):2331-2337 (Pubitemid 32977500)
6. Mertens A, Holvoet P (2001) Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB J 15:2073-2084 (Pubitemid 32927925)
7. Lau BH (2006) Suppression of LDL oxidation by garlic compounds is a possible mechanism of cardiovascular health benefit. J Nutr 136(3 Suppl):765S-768S
8. Goldstein JL, Ho YK, Basu SK, Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76(1):333-337 (Pubitemid 9110191)
9. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 81(12):3883-3887 (Pubitemid 14087823)
10. Haberland ME, Olch CL, Folgelman AM (1984) Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages. J Biol Chem 259(18):11305-11311 (Pubitemid 14007783)
11. Holvoet P, Harris TB, Tracy RP, Verhamme P, Newman AB, Rubin SM, Simonsick EM, Colbert LH, Kritchevsky SB (2003) Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging and Body Composition study. Arterioscler Thromb Vasc Biol 23:1444-1448 (Pubitemid 36994534)
12. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725
13. Beishuizen ED, van de Ree MA, Jukema JW, Tamsma JT, van der Vijver JC, Meinders AE, Putter H, Huisman MV (2004) Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease. Diabetes care 27(12):2887-2892 (Pubitemid 39565054)
14. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580-1588
15. Gladman DD, Ibañez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288-291 (Pubitemid 34118775)
16. Smilde TJ, Trip MD, Wollersheim H, van Wissen S, Kastelein JJP, Stalenhoef AFH (2000) Rationale, design and baseline characteristics of a clinical trial comparing the effects of robust vs conventional cholesterol lowering and intima media thickness in patients with familial hypercholesterolaemia. Clin Drug Invest 20:67-79
17. Fischer CL, Gill C, Forrester MG, Nakamura R (1976) Quantitation of "acute-phase proteins" postoperatively. Value in detection and monitoring of complications. Am J Clin Pathol 66(5):840-846
18. Boizel R, Benhamou PY, Lardy B, Laporte F, Foulon T, Halimi S (2000) Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 23:1679-1685
19. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M (2007) Mannheim Carotid Intima-Media Thickness Consensus (2004-2006). An update on behalf of the advisory board of the 3rd and 4th watching the risk symposium 13th and 15th European stroke conferences, Mannheim, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 23:75-80 (Pubitemid 46112808)
20. Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, Goodpaster B, Harris TB (2004) The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 53(4):1068-1073 (Pubitemid 38436620)
21. Libby P, Ridker PM, Maseri A (2005) Inflammation and atherosclerosis. Circulation 5(105):1135-1143 (Pubitemid 34212626)
22. Sigurdardottir V, Fagerberg B, Hulthe J (2002) Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J Intern Med 252:440-447 (Pubitemid 36706575)
23. Chancharme L, Therond P, Nigon F, Lepage S, Couturier M, Chapman MJ (1999) Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL. Arterioscler Thromb Vasc Biol 19:810-820 (Pubitemid 29135188)
24. Ridker PM, Buring JE, Cook NR, Rifai N (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 107:391-397
25. Olusi SO, George S (2011) Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus. Vasc Health Risk Manag 7:75-80
26. Navab M, Yu R, Gharavi N, Huang W, Ezra N, Lotfizadeh A, Anantharamaiah GM, Alipour N, Van Lenten BJ, Reddy ST, Marelli D (2007) High-density lipoprotein: antioxidant and anti-inflammatory properties. Curr Atheroscler Rep 9(3):244-248 (Pubitemid 47629072)
27. Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy ST, Fogelman AM (2003) Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation 108(22):2751-2756 (Pubitemid 37498976)
28. van Leuven SI, Hezemans R, Levels JH, Snoek S, Stokkers PC, Hovingh GK, Kastelein JJ, Stroes ES, de Groot E, Hommes DW (2007) Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease. J Lipid Res 48(12):2640-2646 (Pubitemid 350272849)
29. Dodani S, Kaur R, Reddy S, Reed GL, Navab M, George V (2008) Can dysfunctional HDL explain high coronary artery disease risk in South Asians? Int J Cardiol 129(1):125-132
30. Hahn BH, Grossman J, Ansell BJ, Skaggs BJ, McMahon M (2008) Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthr Res Ther 10:213
31. Iughetti L, Volta C, Maggi E et al (1999) Circulating antibodies recognizing oxidatively modified low-density lipoprotein in children. Pediatr Res 45:94-99 (Pubitemid 29016781)
32. Wu R, de Faire U, Lemne C et al (1999) Autoantibodies to OxLDL are decreased in individuals with borderline hypertension. Hypertension 33:53-59 (Pubitemid 29061841)
33. Fukumoto M, Shoji T, Emoto M et al (2000) Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler Thromb Vasc Biol 20:703-707 (Pubitemid 30151684)
34. Lopez LR, Buckner TR, Hurkey BL, Kobayashi BL, Matsuura E (2007) Determination of oxidized low-density lipoproteins (ox-LDL) versus ox-LDL/β2GPI complexes for the assessment of autoimmune-mediated atherosclerosis. Ann NY Acad Sci 1109:303-310 (Pubitemid 47511373)
35. Bassi N, Ghirardello A, Iaccarino L, Zampieri S, Rampudda ME, Atzeni F, Sarzi-Puttini P, Shoenfeld Y, Doria A (2007) OxLDL/[beta]2GPI-anti-OxLDL/[beta] 2GPI complex and atherosclerosis in SLE patients. Autoimmun Rev 7:52-58 (Pubitemid 47633392)
36. Petri M, Perez-Gutthann S, Spence D, Hochberg MC (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513-519
37. Petri M, Sepnce D, Bone LR, Hochberg MC (1992) Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices. Medicine (Baltimore) 71:291-302
38. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349(25):2399-2406 (Pubitemid 37542988)
39. Kremers HM, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2004) Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum 50:3450-3457 (Pubitemid 39488669)
40. Turesson C, Jarenros A, Jacobsson L (2004) Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis 63:952-955 (Pubitemid 38961920)
41. Khera A, de Lemos JA, Peshock RM, Lo HS, Stanek HG, Murphy SA, Wians FH Jr, Grundy SM, McGuire DK (2006) Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 113(1):38-43 (Pubitemid 43958486)
42. Kiani AN, Post WS, Magder LS, Petri M (2011) Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus. Rheumatology (Oxford) 50(11):2071-2079
43. del Rincón I, Freeman GL, Haas RW, O'Leary DH, Escalante A (2005) Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 52:3413-3423 (Pubitemid 41612207)
44. Romero-Díaz J, Vargas-Vóracková F, Kimura-Hayama E, Cortázar-Benítez LF, Gijón-Mitre R, Criales S, Cabiedes-Contreras J, Iñiguez-Rodríguez Mdel R, Lara-García EA, Núñez-Alvarez C, Llorente L, Aguilar-Salinas C, Sánchez-Guerrero J (2012) Systemic lupus erythematosus risk factors for coronary artery calcifications. Rheumatology (Oxford) 51(1):110-119
45. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325